My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes.

    Lean ME, Pajonk FG.

    Diabetes Care. 2003 May;26(5):1597-605. Review.PMID: 12716824 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Schizophrenia, diabetes mellitus and antipsychotics]

    Gury C.

    Encephale. 2004 Jul-Aug;30(4):382-91. Review. French. PMID: 15538314 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hyperglycemia and antipsychotic medications.

    Haupt DW, Newcomer JW.

    J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.PMID: 11806485 [PubMed - indexed for MEDLINE]Related articles

    4.

    Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

    Cohen D, Stolk RP, Grobbee DE, Gispen-de Wied CC.

    Diabetes Care. 2006 Apr;29(4):786-91.PMID: 16567816 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Atypical antipsychotics and glucose homeostasis.

    Bergman RN, Ader M.

    J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.PMID: 15816794 [PubMed - indexed for MEDLINE]Related articles

    6.

    Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

    Newcomer JW.

    CNS Drugs. 2005;19 Suppl 1:1-93. Review.PMID: 15998156 [PubMed - indexed for MEDLINE]Related articles

    7.

    Atypical antipsychotic drug use and diabetes.

    Ananth J, Venkatesh R, Burgoyne K, Gunatilake S.

    Psychother Psychosom. 2002 Sep-Oct;71(5):244-54.PMID: 12207104 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management]

    Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

    Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French. PMID: 16389718 [PubMed - indexed for MEDLINE]Related articles

    9.

    Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment.

    Dwyer DS, Bradley RJ, Kablinger AS, Freeman AM 3rd.

    Ann Clin Psychiatry. 2001 Jun;13(2):103-13. Review.PMID: 11534925 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antipsychotic medications: metabolic and cardiovascular risk.

    Newcomer JW.

    J Clin Psychiatry. 2007;68 Suppl 4:8-13. Review.PMID: 17539694 [PubMed - indexed for MEDLINE]Related articles

    11.

    Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.

    Silvestre JS, Prous J.

    Methods Find Exp Clin Pharmacol. 2005 Jun;27(5):289-304.PMID: 16082416 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment]

    Koga M.

    Seishin Shinkeigaku Zasshi. 2003;105(4):473-88. Japanese. PMID: 12806910 [PubMed - indexed for MEDLINE]Related articles

    13.

    Side effects of atypical antipsychotic drugs.

    Ananth J, Parameswaran S, Gunatilake S.

    Curr Pharm Des. 2004;10(18):2219-29. Review.PMID: 15281897 [PubMed - indexed for MEDLINE]Related articles

    14.

    Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.

    Newcomer JW.

    J Clin Psychiatry. 2004;65 Suppl 18:36-46. Review.PMID: 15600383 [PubMed - indexed for MEDLINE]Related articles

    15.

    H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

    Kroeze WK, Hufeisen SJ, Popadak BA, Renock SM, Steinberg S, Ernsberger P, Jayathilake K, Meltzer HY, Roth BL.

    Neuropsychopharmacology. 2003 Mar;28(3):519-26.PMID: 12629531 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Metabolic risk during antipsychotic treatment.

    Newcomer JW.

    Clin Ther. 2004 Dec;26(12):1936-46. Review.PMID: 15823759 [PubMed - indexed for MEDLINE]Related articles

    17.

    Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.

    van Winkel R, De Hert M, Wampers M, Van Eyck D, Hanssens L, Scheen A, Peuskens J.

    J Clin Psychiatry. 2008 Mar;69(3):472-9.PMID: 18348593 [PubMed - indexed for MEDLINE]Related articles

    18.

    A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics.

    Weber M, Wyne K.

    Schizophr Res. 2006 Mar;83(1):95-101. Epub 2006 Feb 28.PMID: 16507343 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.

    Van Gaal LF.

    Eur Neuropsychopharmacol. 2006 Sep;16 Suppl 3:S142-8. Epub 2006 Jul 24. Review.PMID: 16863690 [PubMed - indexed for MEDLINE]Related articles

    20.

    A regional comparison of developing diabetes among VA patients exposed to typical and atypical antipsychotics relative to corticosteroids and proton pump inhibitors.

    Barnett M, Argo T, Alexander B, Perry P.

    Ann Clin Psychiatry. 2006 Jan-Mar;18(1):1-7.PMID: 16517447 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity